AU2022250028A1 - Suspension containing heterocyclidene acetamide derivative - Google Patents

Suspension containing heterocyclidene acetamide derivative Download PDF

Info

Publication number
AU2022250028A1
AU2022250028A1 AU2022250028A AU2022250028A AU2022250028A1 AU 2022250028 A1 AU2022250028 A1 AU 2022250028A1 AU 2022250028 A AU2022250028 A AU 2022250028A AU 2022250028 A AU2022250028 A AU 2022250028A AU 2022250028 A1 AU2022250028 A1 AU 2022250028A1
Authority
AU
Australia
Prior art keywords
aqueous suspension
suspension agent
acetamide
trifluoromethylchroman
ylidene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2022250028A
Other languages
English (en)
Inventor
Yuki Yamashita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Mochida Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd, Mochida Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Publication of AU2022250028A1 publication Critical patent/AU2022250028A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2022250028A 2021-03-30 2022-03-29 Suspension containing heterocyclidene acetamide derivative Pending AU2022250028A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021057713 2021-03-30
JP2021-057713 2021-03-30
PCT/JP2022/015691 WO2022210784A1 (ja) 2021-03-30 2022-03-29 ヘテロシクリデンアセトアミド誘導体含有懸濁液

Publications (1)

Publication Number Publication Date
AU2022250028A1 true AU2022250028A1 (en) 2023-11-16

Family

ID=83459508

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2022250028A Pending AU2022250028A1 (en) 2021-03-30 2022-03-29 Suspension containing heterocyclidene acetamide derivative

Country Status (10)

Country Link
US (2) US12564553B2 (https=)
EP (1) EP4316485A4 (https=)
JP (3) JP7175431B1 (https=)
KR (1) KR20230163502A (https=)
CN (1) CN117120048A (https=)
AU (1) AU2022250028A1 (https=)
BR (1) BR112023019820A2 (https=)
CA (1) CA3215750A1 (https=)
MX (1) MX2023011649A (https=)
WO (1) WO2022210784A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3262434A1 (en) 2022-07-20 2025-06-12 Asahi Kasei Kabushiki Kaisha Hyaluronic acid derivative drug composition and drug composition
WO2025206172A1 (ja) * 2024-03-28 2025-10-02 千寿製薬株式会社 電子線滅菌処理したヘテロシクリデンアセトアミド誘導体含有組成物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61164725A (ja) 1985-01-11 1986-07-25 Inoue Japax Res Inc ワイヤ電極案内
JPH07304663A (ja) * 1994-03-18 1995-11-21 Senju Pharmaceut Co Ltd 眼圧降下用点眼剤
EP0686393B1 (en) 1994-03-18 1998-05-20 Senju Pharmaceutical Co., Ltd. Ophthalmic preparations containing sarpogrelate for reducing intraocular pressure
JP3402195B2 (ja) * 1997-05-14 2003-04-28 千寿製薬株式会社 再分散性の良い水性懸濁液剤
WO1998051281A1 (en) 1997-05-14 1998-11-19 Senju Pharmaceutical Co., Ltd. Aqueous suspension preparations with excellent redispersibility
NZ565080A (en) 2005-07-22 2011-03-31 Mochida Pharm Co Ltd Novel heterocyclidene acetamide derivative
WO2008123396A1 (ja) * 2007-03-29 2008-10-16 Santen Pharmaceutical Co., Ltd. フルオロメトロンを含有する懸濁型点眼剤
ES2493641T3 (es) * 2007-06-28 2014-09-12 Cydex Pharmaceuticals, Inc. Administración nasal de soluciones acuosas de corticosteroides
JP6230743B1 (ja) * 2017-05-31 2017-11-15 持田製薬株式会社 ヘテロシクリデンアセトアミド誘導体の結晶
WO2021039023A1 (ja) 2019-08-23 2021-03-04 持田製薬株式会社 ヘテロシクリデンアセトアミド誘導体の製造方法
CN112409191A (zh) 2019-08-23 2021-02-26 持田制药株式会社 光学活性的氨基醇的制备方法
JP6966667B2 (ja) * 2019-08-27 2021-11-17 参天製薬株式会社 ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物
JP7419728B2 (ja) 2019-09-27 2024-01-23 ブラザー工業株式会社 通信装置と通信装置のためのコンピュータプログラム
MY207759A (en) 2019-10-04 2025-03-17 Mochida Pharm Co Ltd Pharmaceutical drug containing heterocyclidene acetamide derivative

Also Published As

Publication number Publication date
CA3215750A1 (en) 2022-10-06
US20240180827A1 (en) 2024-06-06
JP2023099107A (ja) 2023-07-11
US12527740B2 (en) 2026-01-20
JPWO2022210784A1 (https=) 2022-10-06
US20250134808A1 (en) 2025-05-01
JP7175431B1 (ja) 2022-11-18
KR20230163502A (ko) 2023-11-30
MX2023011649A (es) 2023-10-11
JP2023011898A (ja) 2023-01-24
EP4316485A4 (en) 2025-03-26
BR112023019820A2 (pt) 2023-11-07
WO2022210784A1 (ja) 2022-10-06
EP4316485A1 (en) 2024-02-07
JP7273235B2 (ja) 2023-05-12
CN117120048A (zh) 2023-11-24
US12564553B2 (en) 2026-03-03

Similar Documents

Publication Publication Date Title
US12527740B2 (en) Suspension containing heterocyclidene acetamide derivative
EP3612228B1 (en) Iodine compositions
AU2005208869B2 (en) Aqueous Pharmaceutical Compositions of 2,6-Diisopropylphenol (propofol) and Their Uses
WO2015105135A1 (ja) ピリジルアミノ酢酸化合物含有医薬組成物
JP6178028B1 (ja) ドルゾラミドとチモロールと界面活性剤を含有する医薬組成物
JP6903448B2 (ja) ドルゾラミドとブリモニジンを含む医薬組成物
JP2012206977A (ja) 眼科用組成物
JP7589393B2 (ja) 滅菌処理したヘテロシクリデンアセトアミド誘導体含有懸濁液
CA3000634C (en) Novel ophthalmic composition comprising rebamipide and method for preparing the same
WO2015068105A1 (en) An improved process for manufacturing sterile ophthalmic pharmaceutical suspensions
JP7589394B2 (ja) ヘテロシクリデンアセトアミド誘導体を含む配合剤
JP2007016024A (ja) ロフルミラスト点眼液
CA3268119A1 (en) Sterilized heterocyclidene-acetamide-derivative-containing suspension
US12409155B1 (en) Ready to use LET formulations
JP6730500B2 (ja) 水性液剤
WO2025206172A1 (ja) 電子線滅菌処理したヘテロシクリデンアセトアミド誘導体含有組成物
JP2022123792A (ja) 水性医薬組成物